Vaxinano: Valuation, Funding & Investors
Vaxinano is a pioneering biotech company focused on developing prophylactic and therapeutic nasal vaccines. The company is advancing its flagship vaccines and immuno-therapies targeting diseases such as leishmaniasis, toxoplasmosis, and colibacillosis into clinical trials.
Leadership & Board
- Current Number of Employees
- 15
- Current LinkedIn Followers
- 2,057
Latest Estimated Valuation
- Total Amount Raised
- $6M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $6M
- Latest Funding Round
- Investment
Employee Trend
Vaxinano had 15 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
15Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Vaxinano had 2,057 followers as of October 26, 2026. The number of followers increased by 4 (0.19%) week-over-week.
2,057Latest Followers Count
4(0.19%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Investment | $6.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| TCD Capital | Investment |
| Captech Santé | Investment |
| Nord France Amorçage | Investment |
| Wiseed | Investment |
| BPI France | Investment |
Similar Companies
A snapshot of private companies similar to Vaxinano, helping you discover and navigate related company profiles.
Related News and Analysis
